AdventRx submits approval application for chemotherapy drug
SAN DIEGO A drug maker in Southern California plans to submit an approval application for a new chemotherapy drug by the end of the year.
AdventRx Pharmaceuticals announced Tuesday that it would submit a new drug application to the Food and Drug Administration for its chemotherapy emulsion ANX-530 (vinorelbine).
“Our recently completed manufacturing activities represented the last major hurdle before our NDA submission,” AdventRx principal executive officer Brian Culley said in a statement. “While we continue to evaluate the bioequivalence and preclinical data, we have begun the substantial process of compiling the information required for a submission, which we expect to take place by the end of this year.”
Generex appoints Rubinfeld as chief scientific adviser
WORCESTER, Mass. One of the original founders of biotech giant Amgen has accepted an advisory position at a company that develops drugs delivered through the inner lining of the mouth.
Generex Biotechnology Corp. announced Tuesday the appointment of Joseph Rubinfeld as chief scientific adviser. The company said Rubinfeld would help the company develop and implement product commercialization plans for its drug delivery platform and synthetic vaccine platform technology programs.
Rubinfeld has worked in pharmaceutical and consumer product development for 50 years. His work has included helping develop the antibiotic amoxicillin and the first synthetic biodegradable detergent.
Becton, Dickinson and Co. to donate insulin injections through Direct Relief
FRANKLIN LAKES, N.J. A company that develops medical devices and technology plans to donate 5 million insulin syringes and pen needles to diabetes patients struggling to manage their disease because of the economic crisis.
Becton, Dickinson and Co. announced a nationwide program Tuesday to distribute the supplies through Direct Relief to more than 1,000 community health centers and free clinics.
“To avoid the debilitating and costly complications of diabetes, patients must effectively manage their conditions,” BD Medical – Diabetes Care president Linda Tharby said in a statement. “Insulin injections often play a vital role in this daily effort, and BD believes that patients who have fallen on tough times should not forego this critical part of their treatment regimen.”